KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to 0.21.

  • Eli Lilly's Equity Ratio rose 955.86% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year increase of 955.86%. This contributed to the annual value of 0.18 for FY2024, which is 682.2% up from last year.
  • As of Q3 2025, Eli Lilly's Equity Ratio stood at 0.21, which was up 955.86% from 0.18 recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's Equity Ratio peaked at 0.22 during Q4 2022, and registered a low of 0.14 during Q2 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.19 (2024), whereas its average is 0.19.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 9485.7% in 2021, then plummeted by 2204.62% in 2023.
  • Quarter analysis of 5 years shows Eli Lilly's Equity Ratio stood at 0.19 in 2021, then increased by 16.08% to 0.22 in 2022, then decreased by 22.05% to 0.17 in 2023, then increased by 6.82% to 0.18 in 2024, then rose by 14.45% to 0.21 in 2025.
  • Its last three reported values are 0.21 in Q3 2025, 0.18 for Q2 2025, and 0.18 during Q1 2025.